Loading
Teenagers with cancers that are really adult cancers, like melanoma or sarcoma, are barred from adult trials by an age line at 18. Letting them in from age 12, where biology and dosing allow, would give them access years earlier.
Adult oncology trials in histologies that occur in adolescents (melanoma, sarcomas, Hodgkin lymphoma, germ cell tumours, colorectal in Lynch syndrome) set the minimum age at 12 with weight-based dosing where required and paediatric assent, as FDA guidance permits. Sponsors would need to justify an age floor above 12 in these histologies.
Shares Rare and paediatric cancers without markets, Sarcomas (soft tissue, bone, GIST).
Shares Rare and paediatric cancers without markets, Sarcomas (soft tissue, bone, GIST).
Shares Rare and paediatric cancers without markets, Sarcomas (soft tissue, bone, GIST).
Shares Rare and paediatric cancers without markets, Hodgkin lymphoma.
Shares Trials do not represent the people who get cancer, Hodgkin lymphoma.
Shares Rare and paediatric cancers without markets, Sarcomas (soft tissue, bone, GIST).
Shares Rare and paediatric cancers without markets, Sarcomas (soft tissue, bone, GIST).
Shares Rare and paediatric cancers without markets, Sarcomas (soft tissue, bone, GIST).